Urolift Treatment for BPH: Surpassing 250,000 Men as Best Option
August 2, 2021
Benign prostatic hyperplasia (BPH) is a common medical condition that affects 42 million men in the U.S., with more than 12 million men under the care of a urologist for the condition.
This common, non-cancerous enlargement of the prostate occurs as men age and can interrupt sleep, cause urinary problems, and decrease quality of life.
The prostate is a small gland located below the neck of the bladder and the urethra runs through the center of the prostate from the bladder and through the penis where urine flows out. As the prostate grows and enlarges, it begins to press on and obstruct the urethra causing symptoms such as frequent daytime urination, getting up at night frequently to urinate, a weak or slow stream, the feeling of not emptying the bladder completely, an urgent need to urinate or difficulty starting a urinary stream. Although BPH is a benign condition, many men find it disruptive to their lives and often have symptoms that begin at all ages.
A treatment option that globally over 250,00 patients have undergone called Urolift has gained a reputation as the best and often first treatment for BPH.
Many men are looking for alternatives to the typical medications and traditional, invasive surgeries for treatment which lessen side effects and risks.
Urolift is a minimally invasive treatment indicated for the treatment of symptoms of an enlarged prostate in men 45 years or older. UroLift permanent implants, delivered during an outpatient procedure, relieve prostate obstruction without heating, cutting, destruction or removing prostate tissue. UroLift System is the only leading BPH procedure shown to not cause new onset, sustained erectile or ejaculatory dysfunction.
The most common adverse events are temporary and can include temporary blood in the urine, burning with urination, urinary urgency, pelvic pain, and urgency.
Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention.
Urolift is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. For a comparson between top BPH treatments, see Urolift vs. Rezum.
If you are interested in learning more about BPH treatment, including Urolift, contact Austin Urology Institute to schedule an appointment with a provider at 512.694.8888.
Virtual Visits Available
We offer both in-clinic and remote telemedicine consultations worldwide.